Cardiawave has obtained clinical trial authorizations for its non-invasive treatment of aortic stenosis.
Authorizations have been granted by ethical committees and competent authorities to begin clinical trials in France and the Netherlands, with imminent approval in Serbia as well. A trial in 10 patients will therefore commence shortly.
Full article available on DotMed.com ⬇️
Our testimony and advice as recently winners of PME Instrument Phase 2, along with Medicen Paris Region:
Cardiawave will attend the Medteq Innovation Summit in Laval, Québec on January 14th!
Benjamin BERTRAND is representing Cardiawave at the Biotech Showcase and RESI Conferences in San Francisco from January, 7th to 9th!